Do analysts rate DFNS or FTII?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nukkleus 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 FutureTech II Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable valuation and earnings, DFNS or FTII?

Nukkleus has higher revenue and earnings than FutureTech II Acquisition. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nukkleus $5.91M 1.72 $78.55M -$2.94 N/A FutureTech II Acquisition N/A N/A N/A N/A N/A

Is DFNS or FTII more profitable?

FutureTech II Acquisition's return on equity of 0.00% beat Nukkleus' return on equity. Company Net Margins Return on Equity Return on Assets Nukkleus N/A -190.60% -40.70% FutureTech II Acquisition N/A N/A N/A

Do analysts rate LOAN or DFNS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Manhattan Bridge Capital 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Nukkleus 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to LOAN or DFNS?

In the previous week, Nukkleus had 8 more articles in the media than Manhattan Bridge Capital. MarketBeat recorded 11 mentions for Nukkleus and 3 mentions for Manhattan Bridge Capital. Manhattan Bridge Capital's average media sentiment score of 0.63 beat Nukkleus' score of 0.30 indicating that Manhattan Bridge Capital is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Manhattan Bridge Capital 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nukkleus 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer DFNS or CLPR?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nukkleus 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Clipper Realty 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is DFNS or CLPR more profitable?

Nukkleus has a net margin of 0.00% compared to Clipper Realty's net margin of -7.10%. Clipper Realty's return on equity of 0.00% beat Nukkleus' return on equity. Company Net Margins Return on Equity Return on Assets Nukkleus N/A -190.60% -40.70% Clipper Realty -7.10% N/A -0.87%

Do analysts rate DFNS or ALCY?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nukkleus 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Alchemy Investments Acquisition Corp 1 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, DFNS or ALCY?

Nukkleus has higher revenue and earnings than Alchemy Investments Acquisition Corp 1. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nukkleus $5.91M 1.72 $78.55M -$2.94 N/A Alchemy Investments Acquisition Corp 1 N/A N/A N/A N/A N/A

Is DFNS or ALCY more profitable?

Alchemy Investments Acquisition Corp 1's return on equity of 0.00% beat Nukkleus' return on equity. Company Net Margins Return on Equity Return on Assets Nukkleus N/A -190.60% -40.70% Alchemy Investments Acquisition Corp 1 N/A N/A N/A

Do analysts rate BKHA or DFNS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Black Hawk Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Nukkleus 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, BKHA or DFNS?

Nukkleus has higher revenue and earnings than Black Hawk Acquisition. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Black Hawk Acquisition N/A N/A N/A N/A N/A Nukkleus $5.91M 1.72 $78.55M -$2.94 N/A

Is BKHA or DFNS more profitable?

Black Hawk Acquisition's return on equity of 0.00% beat Nukkleus' return on equity. Company Net Margins Return on Equity Return on Assets Black Hawk Acquisition N/A N/A N/A Nukkleus N/A -190.60% -40.70%

Nukkleus (DFNS) Competitors

$0.17 -0.01 (-5.45%)

As of 09:51 AM Eastern

Compare

DFNS vs. FTII, LOAN, CLPR, ALCY, and BKHA

Should you buy Nukkleus stock or one of its competitors? MarketBeat compares Nukkleus with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nukkleus include FutureTech II Acquisition (FTII), Manhattan Bridge Capital (LOAN), Clipper Realty (CLPR), Alchemy Investments Acquisition Corp 1 (ALCY), and Black Hawk Acquisition (BKHA). These companies are all part of the "trading" industry.

How does Nukkleus compare to FutureTech II Acquisition?

Nukkleus (NASDAQ:DFNS) and FutureTech II Acquisition (NASDAQ:FTII) are both small-cap trading companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nukkleus	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
FutureTech II Acquisition	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Nukkleus has a beta of -6, meaning that its stock price is 700% less volatile than the broader market. Comparatively, FutureTech II Acquisition has a beta of -0.03, meaning that its stock price is 103% less volatile than the broader market.

Nukkleus has higher revenue and earnings than FutureTech II Acquisition.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nukkleus	$5.91M	1.72	$78.55M	-$2.94	N/A
FutureTech II Acquisition	N/A	N/A	N/A	N/A	N/A

12.5% of Nukkleus shares are held by institutional investors. Comparatively, 65.8% of FutureTech II Acquisition shares are held by institutional investors. 22.1% of Nukkleus shares are held by insiders. Comparatively, 9.3% of FutureTech II Acquisition shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Nukkleus had 11 more articles in the media than FutureTech II Acquisition. MarketBeat recorded 11 mentions for Nukkleus and 0 mentions for FutureTech II Acquisition. Nukkleus' average media sentiment score of 0.30 beat FutureTech II Acquisition's score of 0.00 indicating that Nukkleus is being referred to more favorably in the media.

Company	Overall Sentiment
Nukkleus	Neutral
FutureTech II Acquisition	Neutral

FutureTech II Acquisition's return on equity of 0.00% beat Nukkleus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nukkleus	N/A	-190.60%	-40.70%
FutureTech II Acquisition	N/A	N/A	N/A

Summary

Nukkleus beats FutureTech II Acquisition on 5 of the 9 factors compared between the two stocks.

How does Nukkleus compare to Manhattan Bridge Capital?

Manhattan Bridge Capital (NASDAQ:LOAN) and Nukkleus (NASDAQ:DFNS) are both small-cap trading companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings, dividends and media sentiment.

Nukkleus has lower revenue, but higher earnings than Manhattan Bridge Capital. Nukkleus is trading at a lower price-to-earnings ratio than Manhattan Bridge Capital, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Manhattan Bridge Capital	$6.80M	7.41	$5.11M	$0.44	10.03
Nukkleus	$5.91M	1.72	$78.55M	-$2.94	N/A

Manhattan Bridge Capital has a beta of 0.17, indicating that its stock price is 83% less volatile than the broader market. Comparatively, Nukkleus has a beta of -6, indicating that its stock price is 700% less volatile than the broader market.

In the previous week, Nukkleus had 8 more articles in the media than Manhattan Bridge Capital. MarketBeat recorded 11 mentions for Nukkleus and 3 mentions for Manhattan Bridge Capital. Manhattan Bridge Capital's average media sentiment score of 0.63 beat Nukkleus' score of 0.30 indicating that Manhattan Bridge Capital is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Manhattan Bridge Capital	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nukkleus	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Manhattan Bridge Capital has a net margin of 59.24% compared to Nukkleus' net margin of 0.00%. Manhattan Bridge Capital's return on equity of 11.59% beat Nukkleus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Manhattan Bridge Capital	59.24%	11.59%	7.89%
Nukkleus	N/A	-190.60%	-40.70%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Manhattan Bridge Capital	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Nukkleus	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

21.8% of Manhattan Bridge Capital shares are owned by institutional investors. Comparatively, 12.5% of Nukkleus shares are owned by institutional investors. 24.6% of Manhattan Bridge Capital shares are owned by insiders. Comparatively, 22.1% of Nukkleus shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Manhattan Bridge Capital beats Nukkleus on 12 of the 14 factors compared between the two stocks.

How does Nukkleus compare to Clipper Realty?

Nukkleus (NASDAQ:DFNS) and Clipper Realty (NYSE:CLPR) are both small-cap trading companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nukkleus	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Clipper Realty	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

12.5% of Nukkleus shares are owned by institutional investors. Comparatively, 37.6% of Clipper Realty shares are owned by institutional investors. 22.1% of Nukkleus shares are owned by company insiders. Comparatively, 54.6% of Clipper Realty shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Nukkleus has higher earnings, but lower revenue than Clipper Realty. Clipper Realty is trading at a lower price-to-earnings ratio than Nukkleus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nukkleus	$5.91M	1.72	$78.55M	-$2.94	N/A
Clipper Realty	$151.92M	0.33	-$19.90M	-$0.81	N/A

Nukkleus has a beta of -6, indicating that its share price is 700% less volatile than the broader market. Comparatively, Clipper Realty has a beta of 0.96, indicating that its share price is 4% less volatile than the broader market.

In the previous week, Nukkleus had 11 more articles in the media than Clipper Realty. MarketBeat recorded 11 mentions for Nukkleus and 0 mentions for Clipper Realty. Nukkleus' average media sentiment score of 0.30 beat Clipper Realty's score of 0.00 indicating that Nukkleus is being referred to more favorably in the media.

Company	Overall Sentiment
Nukkleus	Neutral
Clipper Realty	Neutral

Nukkleus has a net margin of 0.00% compared to Clipper Realty's net margin of -7.10%. Clipper Realty's return on equity of 0.00% beat Nukkleus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nukkleus	N/A	-190.60%	-40.70%
Clipper Realty	-7.10%	N/A	-0.87%

Summary

Clipper Realty beats Nukkleus on 8 of the 14 factors compared between the two stocks.

How does Nukkleus compare to Alchemy Investments Acquisition Corp 1?

Nukkleus (NASDAQ:DFNS) and Alchemy Investments Acquisition Corp 1 (NASDAQ:ALCY) are both small-cap trading companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations, risk and media sentiment.

Nukkleus has higher revenue and earnings than Alchemy Investments Acquisition Corp 1.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nukkleus	$5.91M	1.72	$78.55M	-$2.94	N/A
Alchemy Investments Acquisition Corp 1	N/A	N/A	N/A	N/A	N/A

Nukkleus has a beta of -6, suggesting that its share price is 700% less volatile than the broader market. Comparatively, Alchemy Investments Acquisition Corp 1 has a beta of -0.04, suggesting that its share price is 104% less volatile than the broader market.

In the previous week, Nukkleus had 11 more articles in the media than Alchemy Investments Acquisition Corp 1. MarketBeat recorded 11 mentions for Nukkleus and 0 mentions for Alchemy Investments Acquisition Corp 1. Nukkleus' average media sentiment score of 0.30 beat Alchemy Investments Acquisition Corp 1's score of 0.00 indicating that Nukkleus is being referred to more favorably in the media.

Company	Overall Sentiment
Nukkleus	Neutral
Alchemy Investments Acquisition Corp 1	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nukkleus	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Alchemy Investments Acquisition Corp 1	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Alchemy Investments Acquisition Corp 1's return on equity of 0.00% beat Nukkleus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nukkleus	N/A	-190.60%	-40.70%
Alchemy Investments Acquisition Corp 1	N/A	N/A	N/A

12.5% of Nukkleus shares are owned by institutional investors. Comparatively, 92.5% of Alchemy Investments Acquisition Corp 1 shares are owned by institutional investors. 22.1% of Nukkleus shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Nukkleus and Alchemy Investments Acquisition Corp 1 tied by winning 4 of the 8 factors compared between the two stocks.

How does Nukkleus compare to Black Hawk Acquisition?

Black Hawk Acquisition (NASDAQ:BKHA) and Nukkleus (NASDAQ:DFNS) are both small-cap trading companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and profitability.

In the previous week, Nukkleus had 10 more articles in the media than Black Hawk Acquisition. MarketBeat recorded 11 mentions for Nukkleus and 1 mentions for Black Hawk Acquisition. Black Hawk Acquisition's average media sentiment score of 1.87 beat Nukkleus' score of 0.30 indicating that Black Hawk Acquisition is being referred to more favorably in the media.

Company	Overall Sentiment
Black Hawk Acquisition	Very Positive
Nukkleus	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Black Hawk Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Nukkleus	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

12.5% of Nukkleus shares are held by institutional investors. 22.1% of Nukkleus shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Black Hawk Acquisition has a beta of 0.03, indicating that its share price is 97% less volatile than the broader market. Comparatively, Nukkleus has a beta of -6, indicating that its share price is 700% less volatile than the broader market.

Black Hawk Acquisition's return on equity of 0.00% beat Nukkleus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Black Hawk Acquisition	N/A	N/A	N/A
Nukkleus	N/A	-190.60%	-40.70%

Nukkleus has higher revenue and earnings than Black Hawk Acquisition.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Black Hawk Acquisition	N/A	N/A	N/A	N/A	N/A
Nukkleus	$5.91M	1.72	$78.55M	-$2.94	N/A

Summary

Black Hawk Acquisition and Nukkleus tied by winning 4 of the 8 factors compared between the two stocks.

Get Nukkleus News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DFNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DFNS vs. The Competition

Export

Metric	Nukkleus	Technology Services Industry	Business Sector	NASDAQ Exchange
Market Cap	$10.14M	$4.29B	$6.71B	$12.10B
Dividend Yield	N/A	2.14%	3.21%	5.90%
P/E Ratio	-0.06	39.40	27.67	23.95
Price / Sales	1.72	45.13	374.24	99.09
Price / Cash	0.05	35.92	22.49	53.91
Price / Book	-0.23	4.53	5.72	6.31
Net Income	$78.55M	$31.97M	$204.76M	$337.22M
7 Day Performance	-17.46%	-4.49%	-1.64%	-0.91%
1 Month Performance	-50.53%	-6.04%	-1.71%	-0.32%
1 Year Performance	-98.38%	17.70%	25.13%	26.19%

Nukkleus Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DFNS Nukkleus	0.4608 of 5 stars	$0.17 -5.4%	N/A	-98.4%	$10.14M	$5.91M	N/A	12	Trending News Short Interest Increase Analyst Revision
FTII FutureTech II Acquisition	N/A	$12.02 flat	N/A	N/A	$51.57M	N/A	N/A	2
LOAN Manhattan Bridge Capital	2.3037 of 5 stars	$4.38 +0.9%	N/A	-16.1%	$50.06M	$8.67M	9.95	6	News Coverage
CLPR Clipper Realty	0.8046 of 5 stars	$3.09 -1.9%	N/A	-16.0%	$49.93M	$153.20M	N/A	140
ALCY Alchemy Investments Acquisition Corp 1	N/A	$11.80 flat	N/A	N/A	$49.65M	N/A	N/A	N/A

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DFNS) was last updated on 6/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nukkleus (DFNS) Competitors

DFNS vs. FTII, LOAN, CLPR, ALCY, and BKHA

How does Nukkleus compare to FutureTech II Acquisition?

Summary

How does Nukkleus compare to Manhattan Bridge Capital?

Summary

How does Nukkleus compare to Clipper Realty?

Summary

How does Nukkleus compare to Alchemy Investments Acquisition Corp 1?

Summary

How does Nukkleus compare to Black Hawk Acquisition?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DFNS vs. The Competition

Nukkleus Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nukkleus (DFNS) Competitors

DFNS vs. FTII, LOAN, CLPR, ALCY, and BKHA

How does Nukkleus compare to FutureTech II Acquisition?

Do analysts rate DFNS or FTII?

Which has more risk and volatility, DFNS or FTII?

Which has preferable valuation and earnings, DFNS or FTII?

Do institutionals and insiders have more ownership in DFNS or FTII?

Does the media prefer DFNS or FTII?

Is DFNS or FTII more profitable?

Summary

How does Nukkleus compare to Manhattan Bridge Capital?

Which has higher earnings & valuation, LOAN or DFNS?

Which has more volatility and risk, LOAN or DFNS?

Does the media refer more to LOAN or DFNS?

Is LOAN or DFNS more profitable?

Do analysts rate LOAN or DFNS?

Do institutionals & insiders have more ownership in LOAN or DFNS?

Summary

How does Nukkleus compare to Clipper Realty?

Do analysts prefer DFNS or CLPR?

Do insiders & institutionals believe in DFNS or CLPR?

Which has preferable earnings & valuation, DFNS or CLPR?

Which has more risk and volatility, DFNS or CLPR?

Does the media favor DFNS or CLPR?

Is DFNS or CLPR more profitable?

Summary

How does Nukkleus compare to Alchemy Investments Acquisition Corp 1?

Which has preferable earnings & valuation, DFNS or ALCY?

Which has more risk & volatility, DFNS or ALCY?

Does the media refer more to DFNS or ALCY?

Do analysts rate DFNS or ALCY?

Is DFNS or ALCY more profitable?

Do institutionals & insiders believe in DFNS or ALCY?

Summary

How does Nukkleus compare to Black Hawk Acquisition?

Does the media favor BKHA or DFNS?

Do analysts rate BKHA or DFNS?

Do institutionals & insiders hold more shares of BKHA or DFNS?

Which has more volatility and risk, BKHA or DFNS?

Is BKHA or DFNS more profitable?

Which has preferable earnings and valuation, BKHA or DFNS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DFNS vs. The Competition

Nukkleus Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools